The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Antinociceptive and anti-inflammatory effects of N-acetylcysteine and verapamil in Wistar rats

  • Received : 2019.02.19
  • Accepted : 2019.07.11
  • Published : 2019.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Antinociceptive anti-inflammatory drugs have many adverse effects. The goal of this investigation is to study the probable anti-inflammatory and analgesic effects of verapamil and N-acetylcysteine (NAC) in experimental rats. Methods: Adult male Wistar rats were randomly divided into 4 groups in the antinociceptive study, each containing 6 rats; the normal control group, which received saline (1 mL/kg); the diclofenac group, which received diclofenac sodium (5 mg/kg); the NAC group, which received NAC (125 mg/kg); and the verapamil group, which received verapamil (8 mg/kg). In the anti-inflammatory study, 5 groups were used, the 4 previous groups with the addition of an edema control group, received saline and were subjected to formalin test. Hot plate latency time was recorded for antinociceptive evaluation. Paw edema thickness and biochemical parameters were recorded for anti-inflammatory evaluation. Results: Administration of NAC showed significant prolongation of hot plate latency time at 1 hour when compared to the control group while verapamil showed a significant prolongation of hot plate latency time at 1 and 2 hours when compared to the control group and NAC group values. Administration of NAC and verapamil significantly decreased paw edema thickness at 2, 4, and 8 hours when compared to edema control values. Regarding biochemical markers, NAC and verapamil significantly decreased serum nitric oxide synthase, C-reactive protein, and cyclooxygenase-2 levels compared to the edema control value. In accordance, a marked improvement of histopathological findings was observed with both drugs. Conclusions: NAC and verapamil have antinociceptive and anti-inflammatory effects comparable to diclofenac sodium.

Keywords

References

  1. Swarup A, Agarwal R, Malhotra S, Dube AS. A comparative study of efficacy of gabapentin in inflammation induced neuropathic animal pain models with conventional analgesic diclofenac. Int J Res Med Sci 2016; 4: 1429-32.
  2. Trevisan G, Benemei S, Materazzi S, De Logu F, De Siena G, Fusi C, et al. TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes/macrophages and oxidative stress. Brain 2016; 139: 1361-77. https://doi.org/10.1093/brain/aww038
  3. Hasanvand A, Ahmadizar F, Abbaszadeh A, Amini-Khoei H, Goudarzi M, Abbasnezhad A, et al. The antinociceptive effects of rosuvastatin in chronic constriction injury model of male rats. Basic Clin Neurosci 2018; 9: 251-60.
  4. Howard L Fields. Pain free: modern drugs and neuropathic pain. J Korean Med Sci 2002; 22: 360-7.
  5. McGettigan P, Henry D. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med 2013; 10: e1001388. https://doi.org/10.1371/journal.pmed.1001388
  6. Tardiolo G, Bramanti P, Mazzon E. Overview on the effects of N-acetylcysteine in neurodegenerative diseases. Molecules 2018; 23: E3305. https://doi.org/10.3390/molecules23123305
  7. Triggle DJ. Calcium-channel drugs: structure-function relationships and selectivity of action. J Cardiovasc Pharmacol 1991; 18(Suppl 10): S1-6. https://doi.org/10.1097/00005344-199118101-00002
  8. Hotchkiss RS, Bowling WM, Karl IE, Osborne DF, Flye MW. Calcium antagonists inhibit oxidative burst and nitrite formation in lipopolysaccharide-stimulated rat peritoneal macrophages. Shock 1997; 8: 170-8. https://doi.org/10.1097/00024382-199709000-00004
  9. Liu Y, Lo YC, Qian L, Crews FT, Wilson B, Chen HL, et al. Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation. Neuropharmacology 2011; 60: 373-80. https://doi.org/10.1016/j.neuropharm.2010.10.002
  10. Kalonia H, Kumar P, Kumar A. Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats. Brain Res 2011; 1372: 115-26. https://doi.org/10.1016/j.brainres.2010.11.060
  11. Eteraf-Oskouei T, Mikaily MS, Najafi M. Anti-inflammatory and anti-angiogenesis effects of verapamil on rat air pouch inflammation model. Adv Pharm Bull 2017; 7: 585-91. https://doi.org/10.15171/apb.2017.070
  12. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-10. https://doi.org/10.1016/0304-3959(83)90201-4
  13. Yuan J, Ma H, Cen N, Zhou A, Tao H. A pharmacokinetic study of diclofenac sodium in rats. Biomed Rep 2017; 7: 179-82.
  14. Horst A, de Souza JA, Santos MCQ, Riffel APK, Kolberg C, Partata WA. Effects of N-acetylcysteine on spinal cord oxidative stress biomarkers in rats with neuropathic pain. Braz J Med Biol Res 2017; 50: e6533. https://doi.org/10.1590/1414-431x20176533
  15. Tamaddonfard E, Erfanparast A, Taati M, Dabbaghi M. Role of opioid system in verapamil-induced antinociception in a rat model of orofacial pain. Vet Res Forum 2014; 5: 49-54.
  16. Langerman L, Zakowski MI, Piskoun B, Grant GJ. Hot plate versus tail flick: evaluation of acute tolerance to continuous morphine infusion in the rat model. J Pharmacol Toxicol Methods 1995; 34: 23-7. https://doi.org/10.1016/1056-8719(94)00077-H
  17. Espejo EF, Mir D. Structure of the rat's behaviour in the hot plate test. Behav Brain Res 1993; 56: 171-6. https://doi.org/10.1016/0166-4328(93)90035-O
  18. Vittalrao AM, Shanbhag T, Kumari M, Bairy KL, Shenoy S. Evaluation of antiinflammatory and analgesic activities of alcoholic extract of Kaempferia galanga in rats. Indian J Physiol Pharmacol 2011; 55: 13-24.
  19. Yoon MH, Choi JI. Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test. Anesthesiology 2003; 99: 701-7. https://doi.org/10.1097/00000542-200309000-00027
  20. Van Herck H, Baumans V, Brandt CJ, Hesp AP, Sturkenboom JH, van Lith HA, et al. Orbital sinus blood sampling in rats as performed by different animal technicians: the influence of technique and expertise. Lab Anim 1998; 32: 377-86. https://doi.org/10.1258/002367798780599794
  21. Yamamoto-Fukud T, Shibata Y, Hishikawa Y, Shin M, Yamaguchi A, Kobayashi T, et al. Effects of various decalcification protocols on detection of DNA strand breaks by terminal dUTP nick end labelling. Histochem J 2000; 32: 697-702. https://doi.org/10.1023/A:1004171517639
  22. Giglio CA, Defino HL, da-Silva CA, de-Souza AS, Del Bel EA. Behavioral and physiological methods for early quantitative assessment of spinal cord injury and prognosis in rats. Braz J Med Biol Res 2006; 39: 1613-23. https://doi.org/10.1590/S0100-879X2006001200013
  23. Horst A, Kolberg C, Moraes MS, Riffel AP, Finamor IA, Bello-Klein A, et al. Effect of N-acetylcysteine on the spinal-cord glutathione system and nitric-oxide metabolites in rats with neuropathic pain. Neurosci Lett 2014; 569: 163-8. https://doi.org/10.1016/j.neulet.2014.03.063
  24. Abdollahi M, Nikfar S, Abdoli N. Potentiation by nitric oxide synthase inhibitor and calcium channel blocker of aspartame- induced antinociception in the mouse formalin test. Fundam Clin Pharmacol 2001; 15: 117-23. https://doi.org/10.1046/j.1472-8206.2001.00013.x
  25. Lee IO, Jeong YS. Effects of different concentrations of formalin on paw edema and pain behaviors in rats. J Korean Med Sci 2002; 17: 81-5. https://doi.org/10.3346/jkms.2002.17.1.81
  26. Damas J, Liegeois JF. The inflammatory reaction induced by formalin in the rat paw. Naunyn Schmiedebergs Arch Pharmacol 1999; 359: 220-7. https://doi.org/10.1007/PL00005345
  27. Lasram MM, Lamine AJ, Dhouib IB, Bouzid K, Annabi A, Belhadjhmida N, et al. Antioxidant and anti-inflammatory effects of N-acetylcysteine against malathion-induced liver damages and immunotoxicity in rats. Life Sci 2014; 107: 50-8. https://doi.org/10.1016/j.lfs.2014.04.033
  28. Farshid AA, Tamaddonfard E, Yahyaee F. Effects of histidine and N-acetylcysteine on diclofenac-induced anti-inflammatory response in acute inflammation in rats. Indian J Exp Biol 2010; 48: 1136-42.
  29. Martinez LL, Aparecida De Oliveira M, Fortes ZB. Influence of verapamil and diclofenac on leukocyte migration in rats. Hypertension 1999; 34: 997-1001. https://doi.org/10.1161/01.HYP.34.4.997
  30. Berk M, Malhi GS, Gray LJ, Dean OM. The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 2013; 34: 167-77. https://doi.org/10.1016/j.tips.2013.01.001
  31. Pireddu R, Caddeo C, Valenti D, Marongiu F, Scano A, Ennas G, et al. Diclofenac acid nanocrystals as an effective strategy to reduce in vivo skin inflammation by improving dermal drug bioavailability. Colloids Surf B Biointerfaces 2016; 143: 64-70. https://doi.org/10.1016/j.colsurfb.2016.03.026
  32. Messiha BA, Abo-Youssef AM. Protective effects of fish oil, allopurinol, and verapamil on hepatic ischemia-reperfusion injury in rats. J Nat Sci Biol Med 2015; 6: 351-5. https://doi.org/10.4103/0976-9668.160003
  33. Ray SD, Kamendulis LM, Gurule MW, Yorkin RD, Corcoran GB. Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J 1993; 7: 453-63. https://doi.org/10.1096/fasebj.7.5.8462787
  34. Huang FM, Chou LS, Chou MY, Chang YC. Protective effect of NAC on formaldehyde-containing-ZOE-based root-canalsealers-induced cyclooxygenase-2 expression and cytotoxicity in human osteoblastic cells. J Biomed Mater Res B Appl Biomater 2005; 74: 768-73.
  35. Wang W, Li Z, Meng Q, Zhang P, Yan P, Zhang Z, et al. Chronic calcium channel inhibitor verapamil antagonizes$TNF-{\alpha}$-mediated inflammatory reaction and protects against inflammatory arthritis in mice. Inflammation 2016; 39: 1624-34. https://doi.org/10.1007/s10753-016-0396-1
  36. Kusama K, Yoshie M, Tamura K, Imakawa K, Isaka K, Tachikawa E. Regulatory action of calcium ion on cyclic AMP-enhanced expression of implantation-related factors in human endometrial cells. PLoS One 2015; 10: e0132017. https://doi.org/10.1371/journal.pone.0132017
  37. Ferreira SH, Lorenzetti BB, Poole S. Bradykinin initiates cytokine- mediated inflammatory hyperalgesia. Br J Pharmacol 1993; 110: 1227-31. https://doi.org/10.1111/j.1476-5381.1993.tb13946.x
  38. Pathak S, Stern C, Vambutas A. N-Acetylcysteine attenuates tumor necrosis factor alpha levels in autoimmune inner ear disease patients. Immunol Res 2015; 63: 236-45. https://doi.org/10.1007/s12026-015-8696-3
  39. Talasaz AH, Khalili H, Jenab Y, Salarifar M, Broumand MA, Darabi F. N-Acetylcysteine effects on transforming growth $factor-{\beta}$ and tumor necrosis $factor-{\alpha}$ serum levels as profibrotic and inflammatory biomarkers in patients following ST-segment elevation myocardial infarction. Drugs R D 2013; 13: 199-205. https://doi.org/10.1007/s40268-013-0025-5
  40. Park JH, Kang SS, Kim JY, Tchah H. The antioxidant N-acetylcysteine inhibits inflammatory and apoptotic processes in human conjunctival epithelial cells in a high-glucose environment. Invest Ophthalmol Vis Sci 2015; 56: 5614-21. https://doi.org/10.1167/iovs.15-16909
  41. Li G, Qi XP, Wu XY, Liu FK, Xu Z, Chen C, et al. Verapamil modulates LPS-induced cytokine production via inhibition of NF-kappa B activation in the liver. Inflamm Res 2006; 55: 108-13. https://doi.org/10.1007/s00011-005-0060-y
  42. Guibas GV, Spandou E, Meditskou S, Vyzantiadis TA, Priftis KN, Anogianakis G. N-acetylcysteine exerts therapeutic action in a rat model of allergic rhinitis. Int Forum Allergy Rhinol 2013; 3: 543-9. https://doi.org/10.1002/alr.21145
  43. Bergamini S, Rota C, Canali R, Staffieri M, Daneri F, Bini A, et al. N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase. Nitric Oxide 2001; 5: 349-60. https://doi.org/10.1006/niox.2001.0356
  44. Saddadi F, Alatab S, Pasha F, Ganji MR, Soleimanian T. The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis. Saudi J Kidney Dis Transpl 2014; 25: 66-72. https://doi.org/10.4103/1319-2442.124489
  45. Nascimento MM, Suliman ME, Silva M, Chinaglia T, Marchioro J, Hayashi SY, et al. Effect of oral N-acetylcysteine treatment on plasma inf lammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Perit Dial Int 2010; 30: 336-42. https://doi.org/10.3747/pdi.2009.00073
  46. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-12. https://doi.org/10.1172/JCI200318921
  47. Bakris GL. Implications of albuminuria on kidney disease progression. J Clin Hypertens (Greenwich) 2004; 6(11 Suppl 3): 18-22. https://doi.org/10.1111/j.1524-6175.2004.04065.x
  48. Bleier BS, Kocharyan A, Singleton A, Han X. Verapamil modulates interleukin-5 and interleukin-6 secretion in organotypic human sinonasal polyp explants. Int Forum Allergy Rhinol 2015; 5: 10-3. https://doi.org/10.1002/alr.21436

Cited by

  1. N-acetylcysteine dose-dependently improves the analgesic effect of acetaminophen on the rat hot plate test vol.22, pp.1, 2019, https://doi.org/10.1186/s40360-020-00469-4